EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden and predictors of drug-resistant tuberculosis in Burkina Faso

T. L. Sawadogo, A. P. Yooda, D. Kambiré, A. Simporé, Y. A. Nagalo, A. Diarra, A. A. Zoure, A. Diallo, S. J. E. Paré, A. Combary, T. Saouadogo, G. Sanou und 3 weitere

African Journal of Clinical and Experimental Microbiology · 2026 · 27 (3) · 263-268

DOI: 10.4314/ajcem.v27i3.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Journal of Clinical and Experimental Microbiology, 2026. Verfasst von T. L. Sawadogo und 14 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Burkina Faso, the emergence of resistance within the Mycobacterium tuberculosis complex (MTBC) represents a growing public health challenge, threatening the progress made toward tuberculosis (TB) control. This study aimed to estimate the prevalence of rifampicin- and isoniazid-resistant TB and to identify factors associated with multidrug-resistant TB (MDR-TB) among patients managed at the National Tuberculosis Control Center (CNLAT).Methodology: A cross-sectional study was conducted using samples from 3,485 presumptive and confirmed TB patients received at CNLAT from January 2020 to December 2023. MTBC detection and rifampicin resistance screening were performed using the Xpert MTB/RIF assay. Samples testing rifampicin-resistant were further analyzed with the GenoType MDRplus v2.0 assay to assess concurrent resistance to isoniazid and rifampicin.

Results

The overall prevalence of rifampicin-resistant TB (RR-TB) among 3,485 TB patients was 2.7% (95% CI: 2.2–3.3), 1.9% among new cases and 11.7% among previously treated cases. Of 60 RR-TB cases identified by Xpert MTB/RIF assay tested by GenoType MDRplus, 73.3% (44/60) were confirmed multidrug-resistant (MDR-TB). Significant associations were observed between MDR/RR-TB and age (p=0.044) and previous TB treatment history (p

Zitieren

APA

Sawadogo, T. L., Yooda, A. P., Kambiré, D., Simporé, A., Nagalo, Y. A., Diarra, A., Zoure, A. A., Diallo, A., Paré, S. J. E., Combary, A., Saouadogo, T., Sanou, G., Sanou, A. M., Bonkoungou, I. J. O., & Diabouga, P. S. (2026). Burden and predictors of drug-resistant tuberculosis in Burkina Faso. African Journal of Clinical and Experimental Microbiology, 27(3), 263-268. https://doi.org/10.4314/ajcem.v27i3.2

Vancouver

Sawadogo TL, Yooda AP, Kambiré D, Simporé A, Nagalo YA, Diarra A, et al. Burden and predictors of drug-resistant tuberculosis in Burkina Faso. African Journal of Clinical and Experimental Microbiology. 2026;27(3):263-268. doi:10.4314/ajcem.v27i3.2

BibTeX
@article{Sawadogo2026,
  author = {Sawadogo, T. L. and Yooda, A. P. and Kambiré, D. and Simporé, A. and Nagalo, Y. A. and Diarra, A. and Zoure, A. A. and Diallo, A. and Paré, S. J. E. and Combary, A. and Saouadogo, T. and Sanou, G. and Sanou, A. M. and Bonkoungou, I. J. O. and Diabouga, P. S.},
  title = {Burden and predictors of drug-resistant tuberculosis in Burkina Faso},
  journal = {African Journal of Clinical and Experimental Microbiology},
  year = {2026},
  volume = {27},
  number = {3},
  pages = {263--268},
  doi = {10.4314/ajcem.v27i3.2}
}
Kostenlos starten →